GlassScriptPhysician profile
Mia Wong
NPI 1336874635
$18,948.21
in general payments reported to CMS, 2019-2025
72 companies · $6,232 in 2025
The $6,232 reported for 2025 was more than what 99% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $6,658 · 2024: $6,059 · 2025: $6,232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $18K · Education: $896.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18,052.16 |
| Education | $896.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exelixis INC. | $1,248.55 | 2023-2025 | Cabometyx |
| Janssen Biotech, INC. | $1,107.18 | 2024-2025 | Erleada, Carvykti, Balversa |
| Incyte Corporation | $929.37 | 2023-2025 | Jakafi, Niktimvo, Monjuvi |
| Takeda Pharmaceuticals U.S.A., INC. | $851.20 | 2023-2025 | Fruzaqla, Iclusig, Ninlaro |
| Astrazeneca Pharmaceuticals LP | $847.86 | 2023-2025 | Enhertu, Lynparza, Tagrisso |
| Daiichi Sankyo INC. | $831.36 | 2023-2025 | Enhertu, Datroway |
| Novartis Pharmaceuticals Corporation | $804.95 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $776.08 | 2023-2025 | Keytruda, Lynparza, Welireg |
| Pfizer INC. | $724.91 | 2023-2025 | |
| Celgene Corporation | $658.02 | 2023-2025 | Reblozyl, Opdualag, Pomalyst |
| Astellas Pharma US INC | $634.56 | 2023-2025 | Xospata, Vyloy, Xtandi |
| Genentech USA, INC. | $574.11 | 2023-2025 | Venclexta, Tecentriq, Tecentriq Hybreza |
| Tersera Therapeutics LLC | $535.35 | 2023-2025 | Zoladex, Quzyttir |
| E.R. Squibb & Sons, L.L.C. | $531.08 | 2023-2025 | Opdivo, Opdualag |
| Array Biopharma INC | $496.09 | 2023-2025 | Braftovi, Mektovi, Lorbrena |
Show all 72 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $439.85 | 2023-2025 | Trodelvy |
| Genzyme Corporation | $436.54 | 2023-2025 | |
| Lilly USA, LLC | $379.03 | 2023-2025 | Verzenio, Jaypirca, Retevmo |
| Glaxosmithkline, LLC. | $330.07 | 2023-2025 | Ojjaara, Zejula, Jemperli |
| Abbvie INC. | $324.96 | 2023-2025 | |
| Myriad Genetic Laboratories, INC. | $312.70 | 2023-2024 | Myrisk |
| Seagen INC. | $273.44 | 2023 | Tukysa, Padcev, Tivdak |
| Puma Biotechnology, INC. | $256.78 | 2023-2025 | Nerlynx |
| Bayer Healthcare Pharmaceuticals INC. | $256.32 | 2023-2025 | |
| Sobi, INC | $244.50 | 2023-2025 | |
| Ipsen Biopharmaceuticals, INC | $232.32 | 2023-2025 | Onivyde, Somatuline Depot |
| Boehringer Ingelheim Pharmaceuticals, INC. | $221.52 | 2023-2025 | Gilotrif |
| Deciphera Pharmaceuticals INC. | $208.61 | 2023-2025 | Qinlock, Romvimza, Tgct |
| Amgen INC. | $202.82 | 2023 | Nplate, Vectibix, Xgeva |
| Pharmaessentia USA Corporation | $184.68 | 2023-2025 | Besremi |
| Aveo Pharmaceuticals, INC. | $183.10 | 2023-2025 | Fotivda |
| Blueprint Medicines Corporation | $170.68 | 2023-2025 | Ayvakit |
| Emd Serono, INC. | $170.30 | 2024-2025 | |
| Eisai INC. | $170.23 | 2023-2025 | |
| Taiho Oncology, INC. | $161.20 | 2023-2025 | |
| Jazz Pharmaceuticals INC. | $151.23 | 2024-2025 | |
| Pharmacosmos Therapeutics INC. | $146.58 | 2023 | Monoferric |
| Coherus Oncology, INC. | $132.21 | 2023-2025 | Loqtorzi |
| Adc Therapeutics America, INC. | $121.07 | 2024-2025 | |
| Agios Pharmaceuticals, INC. | $111.29 | 2023-2025 | Pyrukynd |
| Alexion Pharmaceuticals, INC. | $106.10 | 2024-2025 | Ultomiris |
| Karyopharm Therapeutics INC. | $103.85 | 2023-2024 | Xpovio |
| Stemline Therapeutics INC. | $98.18 | 2023-2025 | Orserdu |
| Morphosys, US INC. | $91.64 | 2023 | Monjuvi |
| Progenics Pharmaceuticals, INC. | $79.29 | 2025 | |
| Acrotech Biopharma INC. | $76.09 | 2023-2025 | Beleodaq |
| Sumitomo Pharma America, INC. | $70.94 | 2023-2024 | Orgovyx |
| Springworks Therapeutics, INC. | $67.31 | 2025 | Ogsiveo |
| Genmab U.S., INC. | $66.70 | 2023 | Epkinly |
| Dendreon Pharmaceuticals LLC | $62.86 | 2025 | Provenge |
| Mirati Therapeutics, INC. | $56.85 | 2023-2024 | Krazati |
| Rigel Pharmaceuticals, INC. | $55.08 | 2023-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Recordati_rare_diseases_inc. | $50.00 | 2024 | Sylvant |
| Octapharma USA, INC. | $49.67 | 2023-2025 | Panzyga, Octagam Immune Globulin (Human) |
| Adaptive Biotechnologies Corporation | $48.09 | 2023-2024 | Clonoseq |
| Sun Pharmaceutical Industries INC. | $47.60 | 2023-2024 | Yonsa |
| Immunogen, INC. | $47.59 | 2023-2024 | Elahere, Elahere |
| Novocure INC. | $45.52 | 2024-2025 | Optune Lua (Novottf-200t) |
| Regeneron Healthcare Solutions, INC. | $33.63 | 2025 | Lynozyfic |
| Beigene USA, INC. | $33.55 | 2025 | Tevimbra |
| Emmaus Medical, INC. | $31.53 | 2023-2024 | Endari |
| Geron Corporation | $30.09 | 2025 | Rytelo |
| Apellis Pharmaceuticals, INC. | $28.43 | 2023 | Empaveli |
| Beone Medicines USA, INC. | $28.32 | 2025 | Tevimbra |
| Immunocore Limited | $27.97 | 2024 | Kimmtrak |
| Accord Healthcare, INC. | $23.49 | 2024 | |
| Spectrum Pharmaceuticals INC. | $23.36 | 2023 | Rolvedon |
| Shorla Oncology INC. | $22.15 | 2025 | |
| Kyowa Kirin, INC. | $20.90 | 2023 | Poteligeo |
| G1 Therapeutics, INC. | $17.25 | 2023 | Cosela |
| Chiesi USA, INC. | $16.85 | 2025 | Ferriprox |
| Cumberland Pharmaceuticals, INC. | $14.63 | 2024 | Sancuso |
Drugs and devices associated with these payments
Enhertu $1,073Cabometyx $1,050Keytruda $776Jakafi $620Erleada $605Reblozyl $550Braftovi $496Lynparza $491Mektovi $469Tukysa $466Zoladex $466Opdivo $427Venclexta $401Lorbrena $329Verzenio $329Sarclisa $327Myrisk $313Fruzaqla $310Xalkori $308Xtandi $307Ibrance $279Fabhalta $255Jaypirca $241Carvykti $236Kisqali $235Onivyde $232Somatuline Depot $232Akeega $230Balversa $230Doptelet $222Xospata $220Retevmo $219Iclusig $216Orgovyx $210Epkinly $209Qinlock $209Ayvakit $200Monjuvi $192Besremi $185Fotivda $183Trodelvy $182Talzenna $180Ojjaara $179Rybrevant $176Scemblix $172Lenvima $170Inqovi $161Lonsurf $161Monoferric $147Imbruvica $142Welireg $140Nubeqa $136Elahere $126Gilotrif $121Ninlaro $121Stivarga $121Vitrakvi $121Tecentriq $120Xofigo $119Tagrisso $117Niktimvo $114Cyramza $113Pyrukynd $111Bosulif $109Ultomiris $106Xpovio $104Zejula $103Jemperli $103Vyloy $101Vectibix $101Xgeva $101Nplate $101Orserdu $98.18Tecentriq Hybreza $96.85Padcev $94.76Zepzelca $94.41Nerlynx $92.64Talvey $90.58Promacta $89.68Phesgo $89.42Tivdak $88.88Opdualag $87.93Udenyca $87.65Imfinzi $87.04Itovebi $83.63Alunbrig $83.43Besponsa $82.06Datroway $80.31Wayrilz $79.87Pylarify $79.29Pemazyre $77.02Lumakras $76.75Elrexfio $76.32Beleodaq $76.09Quzyttir $69.70Tecvayli $68.00Ogsiveo $67.31Provenge $62.86Tevimbra $61.87Romvimza $60.69
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mia Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.